BDBM431907 US10550125, Example 5

SMILES CCNc1nc(nn2c(cnc12)C#N)N(C(=O)OCOC(=O)CC(C)(C)c1c(C)cc(C)cc1OP(O)(O)=O)c1cc(cc(N2CCN(CC2)[C@@H](C)C(N)=O)c1Cl)C#N

InChI Key InChIKey=AEBNGBBFOVOYDE-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 431907   

TargetCasein kinase II subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM431907(US10550125, Example 5)
Affinity DataIC50: 550nMAssay Description:The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2020
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha'(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM431907(US10550125, Example 5)
Affinity DataIC50: 55nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2020
Entry Details
Go to US Patent